skip to content

Color has been recognized by Fast Company as a 2024 Next Big Things in Tech Award winner in the Health category. Learn more.

Help your members get ahead of cancer

Your members’ cancer needs extend far beyond healthcare coverage. Support your workforce, no matter where they are in their cancer experience.

Logo BCBS

We are proud to join the Strategic Alliance of the Blue Cross Blue Shield National Labor Office.

Primary care and health plan coverage alone are not enough to change the course of cancer for your members.

65%

of individuals over the age of 21 are behind on at least one recommended cancer screening 1

41%

of individuals with an abnormal colorectal cancer screening do not receive follow-up testing 2

5x

higher medical expenses for survivors compared to members without a history of cancer 3

Proactive and earlier interventions matter at every stage — detection, diagnosis and treatment, and survivorship.

Detect Early

Colorectal cancer detected: Stage 1

46.2

# of days of work missed

$79k

Financial burden (Y1 cancer-related costs)

90.1%

5 year survival likelihood

Late Stage Detection

Colorectal cancer detected: Stage 4

106

of work days missed

$272k

Financial burden (Y1 cancer-related costs)

14.6%

5 year survival likelihood

Improve Treatment

55%

reduction in time to diagnosis and treatment

$8k

average savings from guidelines-based treatment

$20k

average savings per each avoided hospitalization

Transition Back to Health

100%

of participants receive survivorship care plan

36%

reduction in depressive symptoms

$175k

average savings per prevented cancer recurrence

Color supports and engages your members—beginning with screening and continuing on through diagnosis, treatment, and survivorship.

Detect early

The right screenings at the right time change outcomes.

In partnership with the American Cancer Society, Color’s technology and care teams:

Identify individual cancer risk for lifestyle changes and better screening plans

Create personal screening plans to ensure early detection – based on American Cancer Society guidelines

Bring screenings to members – at home, onsite, or through our national imaging network relationships

Manage clinical next steps after abnormal screens to control costs and speed time to resolution

Improve treatment

Complement your existing care management delivery model with Color’s oncologist-led, accessible care.

Initiate missing diagnostic workups to get the right treatment plan in place, faster

Initiate missing diagnostic workups to get the right treatment plan in place, faster

Tackle financial toxicity with advocacy and innovative reimbursement accounts

Provide 24/7 oncologist clinical support to reduce emergency visits

Integrate with and route to existing benefits, such as post-diagnosis support or physical therapy

Transition back to health

Survivorship care minimizes recurrence risk and supports members with their ongoing clinical needs.

Manage 5-year survivorship care to address long-term side effects

Offer clinically-validated emotional and mental health programs to manage depression, stress, and anxiety

Provide personal nutrition plans and lifestyle interventions to reduce risk

“It’s a win-win situation because from a Fund perspective, you’re looking at catching something early. So, you’re looking at savings there. And from a member’s perspective, you’re looking at catching something early and increasing your survival rate.

Maria Scheeler, Executive Director / Administrator, Teamsters Health & Welfare Fund of Philadelphia and Vicinity

Hear from Maria and other personnel and members as they share their experiences with Color Health and how proactive care has helped them take control of cancer. 

International Brotherhood of Teamsters trucks driving on the road
Partnering with Labor leaders:

Teamsters Health & Welfare Fund of Philadelphia and Vicinity

5x
increase in engagement compared to other wellness programs

86%
of participants scheduled a follow-up with a provider after receiving screening results

50%
lower costs than the traditional model for similar services

12%
of participants identified as high-risk for cancer

Want to learn more?

Learn how Color helped Andersen Construction increase those up-to-date on all of their cancer screenings by 26%.

Understand how occupation affects cancer risk

Construct a comprehensive cancer program for your members

Speak with our solutions team.

Want to get in touch with our team? We’re just a click away.

New to Color?

Speak to our team to discuss your cancer strategy and Color’s solution.

Already a patient?

If you need help with your account, have questions for your care team, or have other service-related issues, we’re here.

New to Color?

Whether you want to learn more about Color or you’re ready to start your journey with us, you’re in the right place.

Thanks! Someone from our team will be in touch soon. In the meantime, here are some helpful links:
  • Have a question for our Support team? Email us at support@color.com.
  • Want to buy a Color genetic test for yourself? Order here.
  • Interested in the latest news and content from Color? Visit our resource library or blog.

Already a customer? Get support.

Call us toll-free between 6am and 5pm PT at (844) 352-6567. Those outside the US can reach us at +1 650-651-7116. We’re also available via email at support@color.com.

For frequently asked questions please visit support.color.com.

Thanks! Someone from our team will be in touch soon. In the meantime, here are some helpful links:

    • Questions about a COVID-19 test or results? Click here
    • Interested in a population COVID-19 testing program? Click here
    • Want to buy a Color genetic test for yourself? Click here
    • Looking to claim an employer benefit? Click here
    • Are you a physician looking to offer Color genetic tests? Click here

References

  1. Early Detection Survey, Prevent Cancer Foundation
  2. Measuring the quality of colorectal cancer screening: the importance of follow-up, National Library of Medicine
  3. Trends in Healthcare Expenditures among Adults in the United States by Cancer Diagnosis Status, 2008–2016: A Cross-Sectional Study, NIH